EUVIMEDDécouvrir EUVIMED
Open access

Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival

Xuan Wang, Tianxi Cai, Lu Tian iD, Layla Parast iD

Statistics in Medicine · 2025

DOI: 10.1002/sim.70268 ↗

At a glance

Journal article in Statistics in Medicine, 2025. Written by Xuan Wang and 3 co-authors. Institution: Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA. Major MEDLINE topics: Models, Statistical, Biomarkers. Cited 1 times so far (Crossref); 31 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIDDK (PI: Parast), National Institute of Diabetes and Digestive and Kidney Diseases.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Clinical trials or studies oftentimes require long‐term and/or costly follow‐up of participants to evaluate a novel treatment/drug/vaccine. There has been increasing interest in the past few decades in using short‐term surrogate outcomes as a replacement for the primary outcome, that is, in using the surrogate outcome, which can potentially be observed sooner, to make inferences about the treatment effect on the long‐term primary outcome. Very few of the available statistical methods to evaluate a surrogate are applicable to settings where both the surrogate and the primary outcome are time‐to‐event outcomes subject to censoring. Methods that can handle this setting tend to require parametric assumptions or be limited to assessing only the restricted mean survival time. In this paper, we propose a nonparametric approach to evaluate a censored surrogate outcome, such as time to progression, when the primary outcome is also a censored time‐to‐event outcome, such as time to death, and the treatment effect of interest is the difference in overall survival. Specifically, we define the proportion of the treatment effect on the primary outcome that is explained (PTE) by the censored surrogate outcome in this context, and estimate this proportion by defining and deriving an optimal transformation of the surrogate information. Our approach provides the added advantage of relaxed assumptions to guarantee that the true PTE is within , along with being model‐free. The finite sample performance of our estimators is illustrated via extensive simulation studies and a real data application examining progression‐free survival as a surrogate for overall survival for patients with metastatic colorectal cancer.

Subjects

MeSH terms (MEDLINE)

Models, StatisticalBiomarkersHumansSurvival AnalysisComputer SimulationTreatment OutcomeStatistics, NonparametricClinical Trials as TopicColorectal Neoplasms

Author keywords

nonparametric estimationoverall survivalprogression‐free survivalproportion of treatment effect explainedsurrogate markers

Substances

Biomarkers

Authors and institutions

  • Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
  • Department of Biostatistics, Harvard University, Boston, Massachusetts, USA.
  • Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
  • Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, Texas, USA.

ORCID profiles: Lu Tian, Layla Parast

Funding

  • NIDDK NIH HHS
  • NIDDK (PI: Parast)
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Wang, X., Cai, T., Tian, L., & Parast, L. (2025). Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival. Statistics in Medicine. https://doi.org/10.1002/sim.70268

Vancouver

Wang X, Cai T, Tian L, Parast L. Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival. Statistics in Medicine. 2025. doi:10.1002/sim.70268

BibTeX
@article{Wang2025,
  author = {Wang, Xuan and Cai, Tianxi and Tian, Lu and Parast, Layla},
  title = {Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70268}
}
Start for free →